Toxic effect of an antitumor drug paclitaxel on morphofunctional characteristics of the liver in rats

被引:14
作者
Ermolaeva, L. A. [1 ]
Dubskaya, T. Yu. [1 ]
Fomina, T. I. [1 ]
Vetoshkina, T. V. [1 ]
Gol'dberg, V. E. [1 ]
机构
[1] Russian Acad Sci, Siberian Div, Tomsk Res Ctr, Inst Pharmacol, Tomsk 117901, Russia
关键词
paclitaxel; hepatotoxicity; laboratory rats;
D O I
10.1007/s10517-008-0066-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
Single intravenous injection of paclitaxel to rats in a maximum tolerated dose of 4.6 mg/kg was accompanied by permanent structural and functional changes in the liver. The observed changes were typical of nonspecific reactive hepatitis: infiltration with lymphocytes and macrophages, pyknosis, and focal fatty degeneration of hepatocytes. Liver enzyme activity increased in blood plasma.
引用
收藏
页码:263 / 265
页数:3
相关论文
共 15 条
[1]
Avtandilov GG, 1990, MED MORPHOMETRY MANU
[2]
Bogush T. A., 2001, Voprosy Onkologii (St. Petersburg), V47, P662
[3]
The bioactive Taxol conformation on β-tubulin:: Experimental evidence from highly active constrained analogs [J].
Ganesh, T ;
Guza, RC ;
Bane, S ;
Ravindra, R ;
Shanker, N ;
Lakdawala, AS ;
Snyder, JP ;
Kingston, DGI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (27) :10006-10011
[4]
Understanding tubulin-Taxol interactions: Mutations that impart Taxol binding to yeast tubulin [J].
Gupta, ML ;
Bode, CJ ;
Georg, GI ;
Himes, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) :6394-6397
[5]
Horwitz Susan Band, 1993, Journal of the National Cancer Institute Monographs, V0, P55
[6]
KINZIRSKAYA YA, 2003, KLIN MED MOSCOW, P11
[7]
LARIONOVA VB, 2004, VESTN INTENSIVN TER, P1
[8]
LYU BN, 2000, CANC PROBLEM 21 CENT, P415
[9]
Effects of taxol on isolated rat hepatocyte metabolism [J].
Manzano, A ;
Roig, T ;
Bermudez, J ;
Bartrons, R .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1996, 271 (06) :C1957-C1962
[10]
Comparison of pharmacokinetics and pharmacodynamics of docetaxel and cisplatin in elderly and non-elderly patients: Why is toxicity increased in elderly patients? [J].
Minami, H ;
Ohe, Y ;
Niho, S ;
Goto, K ;
Ohmatsu, H ;
Kubota, K ;
Kakinuma, R ;
Nishiwaki, Y ;
Nokihara, H ;
Sekine, I ;
Saijo, N ;
Hanada, K ;
Ogata, H .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2901-2908